MedTrace Logo

Postprandial Glycemia After Eating a Pasta Dish Made With Resistant Starch.

NCT05988580 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2024-01-12

No results posted yet for this study

Summary

Resistant starch partially resists hydrolyzation by digestive enzymes in humans. Consequently, it is not absorbed in the small intestine and goes directly to the large intestine, where it is fermented by the intestinal microbiota, acting as a prebiotic and stimulating the growth of beneficial bacteria in the colon. In addition, the effect of resistant starch on postprandial glucose metabolism is studying. Thus, the present research on healthy subjects has been proposed.

The main objective is to assess the effect on postprandial glycemia of eating a pasta dish made with resistant starch versus its original version.

For this purpose, a randomized, double blind crossover study has been designed.

Target sample size is 18 subjects.

Conditions

  • Postprandial Glycemia
  • Resistant Starch

Interventions

OTHER

Pasta dish with resistant starch

Pasta dish with 20-22% of resistant starch

OTHER

Original version of pasta dish

Original pasta dish, not reinforced with resistant starch

Sponsors & Collaborators

  • Clinica Universidad de Navarra, Universidad de Navarra

    lead OTHER

Principal Investigators

  • Fermín I Milagro Yoldi, PhD · University of Navarra

  • Idoia Ibero-Baraibar, PhD · University of Navarra

  • Carlos J González-Navarro, PhD · University of Navarra

  • Miguel López-Yoldi, PhD · University of Navarra

  • Salomé Pérez Diez · University of Navarra

  • Blanca Martínez de Morentin · University of Navarra

  • José I Riezu-Boj, PhD · University of Navarra

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2023-10-27
Completion
2023-11-15

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05988580 on ClinicalTrials.gov